The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
about
Ultrasound imaging beyond the vasculature with new generation contrast agentsProduction and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.Preparation of nanobubbles carrying androgen receptor siRNA and their inhibitory effects on androgen-independent prostate cancer when combined with ultrasonic irradiation.Functionalized multiwalled carbon nanotubes as ultrasound contrast agents.PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors.Nanobubbles for enhanced ultrasound imaging of tumors.The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor ImagingStimuli-responsive polymeric nanoparticles for nanomedicine.Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents.Perfluorooctyl bromide traces self-assembled with polymeric nanovesicles for blood pool ultrasound imaging.Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU).Nanodiamond as a vector for siRNA delivery to Ewing sarcoma cells.Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats.Facile synthesis of magnetite/perfluorocarbon co-loaded organic/inorganic hybrid vesicles for dual-modality ultrasound/magnetic resonance imaging and imaging-guided high-intensity focused ultrasound ablation.An intelligent nanotheranostic agent for targeting, redox-responsive ultrasound imaging, and imaging-guided high-intensity focused ultrasound synergistic therapy.Facile Synthesis of Lipid-Perfluorocarbon Nanoemulsion Coated with Silica Shell as an Ultrasound Imaging Agent.Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.Caveolae-mediated mesenchymal stem cell labelling by PSS-coated PLGA PFOB nano-contrast agent for MRI.Carboxyl of Poly(D,L-lactide-co-glycolide) Nanoparticles of Perfluorooctyl Bromide for Ultrasonic Imaging of Tumor.High-performance reoxygenation from PLGA-PEG/PFOB emulsions: a feedback relationship between ROS and HIF-1α.Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.Charged Aerosol DetectionNear infrared labeling of PLGA for in vivo imaging of nanoparticles
P2860
Q27691825-6D413DC3-1418-43D9-8E41-0562C934010EQ30383852-A0E4E4BA-F9B4-449F-81D2-2029802F9E5FQ30438691-24359BE8-E589-4DAD-8814-0AE219ED3C82Q30455580-61DF444A-E97A-4B78-9FCA-DC481F7C7F11Q30468564-2BB3B53C-2E7E-4418-BF3C-D27A9C92C8BEQ30469828-D4EE736D-43CD-4BB0-A79B-B31E98BAD251Q36022403-7F6806DD-B6FD-478C-AA1B-28044C3C959EQ38260625-64455F4E-EBCC-4A4D-A65B-B52C3731B28EQ38269215-6FC45260-B54D-42A1-8A38-DACD3A5970C1Q38774973-CB92BA5D-F463-4C27-96F8-45A698AF1639Q39416590-24756A31-8AB2-4494-A430-D6501ABE831EQ39474651-DB314328-0AC3-4782-A763-5C32DD5A782AQ41888204-EE1DE886-2A88-4DA8-9FC9-8B3A1B05D2CCQ45107913-88C671F0-C55A-4CC1-A772-6D52734AEAACQ45778015-B8F58434-148E-42CD-A12E-F4CABE3612D8Q47228427-BB880F84-813A-498D-B604-0A976696E2BBQ48321057-276E4978-803B-4217-87D1-5F74379644A5Q49589433-AADDA50E-961F-4826-B2E8-815DA26375E8Q54981850-06F06757-B31D-44B4-8229-32F8A37776F3Q55223774-64CCA985-5726-4451-BDAD-A82EA04B495EQ55248750-6FEAED7A-F3F5-4BA6-A4ED-AF1CE232801EQ55348014-A8EEF6D1-C2B2-4074-9651-0884DBEA796AQ57340538-3DB294F3-B491-4AD0-B7F2-34FA2B785B15Q57676500-A6ECB038-33DB-45D4-B17D-FBDAD0623964
P2860
The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The performance of PEGylated n ...... an ultrasound contrast agent.
@en
The performance of PEGylated n ...... an ultrasound contrast agent.
@nl
type
label
The performance of PEGylated n ...... an ultrasound contrast agent.
@en
The performance of PEGylated n ...... an ultrasound contrast agent.
@nl
prefLabel
The performance of PEGylated n ...... an ultrasound contrast agent.
@en
The performance of PEGylated n ...... an ultrasound contrast agent.
@nl
P2093
P50
P1433
P1476
The performance of PEGylated n ...... s an ultrasound contrast agent
@en
P2093
Danielle Jaillard
Danielle Libong
Mathieu Santin
Raquel Díaz-López
Valérie Nicolas
Véronique Marsaud
P304
P356
10.1016/J.BIOMATERIALS.2009.11.044
P577
2009-11-30T00:00:00Z